Vir Biotechnology, Inc. · NASDAQ:VIR
Vir Biotechnology, Inc. shareholders
As of Sep 30, 2026, 257 institutions reported holding Vir Biotechnology, Inc., 81.8% of its shares. Largest: BlackRock, Vanguard and ARCH Venture Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Vir Biotechnology, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 22.4M | 13.1% | +1.77M | Nov 13, 2026 |
| Vanguard | 19.6M | 11.4% | +655K | Nov 16, 2026 |
| ARCH Venture Management, LLC | 12.7M | 7.4% | no change | Nov 16, 2026 |
| Sb Investment Advisers (UK) LTD | 10.9M | 6.4% | no change | Nov 17, 2026 |
| GSK plc | 8.55M | 5.0% | no change | Nov 5, 2026 |
| State Street | 7.82M | 4.6% | −2.14M | Nov 12, 2026 |
| Point72 Asset Management, L.P. | 6.77M | 4.0% | +1.11M | Nov 16, 2026 |
| Dimensional | 3.32M | 1.9% | +198K | Nov 4, 2026 |
| Geode Capital | 3.02M | 1.8% | −329K | Nov 6, 2026 |
| Mpm Bioimpact LLC | 2.81M | 1.6% | new | Nov 16, 2026 |